PPB Kenya: Launches Nationwide Medicine Supply Chain Inspection

• The Pharmacy and Poisons Board (PPB) is launching a nationwide inspection to enhance oversight of Kenya's medicine supply chain.
• The initiative targets hospitals, pharmacies, wholesalers, and transporters to strengthen compliance with Good Storage and Distribution Practices (GSDP).
• Inspections will cover storage conditions, temperature controls, documentation, product traceability, and handling of temperature-sensitive items.
• In the previous fiscal year, 3,453 inspections resulted in an 82.4% compliance rate, with non-compliant premises facing closure and arrests.
• Entities are urged to review operations and address compliance gaps, as robust traceability and adherence to GSDP are crucial for public health and preventing substandard products.

Reliable records and effective traceability are indispensable for establishing the origin and movement of products, facilitating prompt regulatory action when quality concerns emerge.

The Pharmacy and Poisons Board (PPB) in Kenya has announced a significant expansion of its regulatory oversight across the entire medicine supply chain, initiating a nationwide compliance inspection. This extensive exercise targets a broad spectrum of pharmaceutical entities, including public and private hospital pharmacies, retail pharmacies, pharmaceutical wholesalers, and transporters. The primary objective is to reinforce adherence to Good Storage and Distribution Practices (GSDP), thereby safeguarding the quality, safety, and effectiveness of health products from manufacturing through to patient delivery.

Dr. Ahmed I. Mohamed, the Chief Executive Officer of the PPB, underscored the critical need for sustained oversight beyond the initial manufacturing stage. He emphasized that improper storage, transportation, or handling can severely compromise medical products before they ever reach patients. The PPB aims to ensure that all medicines are stored, transported, and managed under their approved conditions, thereby preserving their integrity throughout the distribution network. This proactive measure forms part of the Board's ongoing commitment to strengthening pharmaceutical compliance across Kenya.

The upcoming PPB Kenya medicine supply chain inspection will delve into various critical aspects of operations. Inspectors will meticulously assess storage conditions, temperature and humidity controls, transportation protocols, comprehensive documentation, stock management systems, and product traceability mechanisms. Furthermore, procedures for handling product complaints and recalls will be scrutinized to ensure efficiency and public safety.

Particular emphasis will be placed on temperature-sensitive products, such as vaccines, insulin, and biological medicines, which necessitate stringent cold chain regulations. Facilities and transporters handling these items must demonstrate appropriate monitoring systems, maintain accurate temperature records, and exhibit effective responses to any temperature excursions. Regulated entities are also required to prove they possess suitable premises and equipment, employ qualified personnel, maintain documented operating procedures, and have robust contingency plans for incidents like power interruptions or equipment failures that could impact product quality. The inspections will also verify that products are sourced from authorized suppliers and distributed exclusively to appropriately authorized recipients, while also examining arrangements for identifying, segregating, and managing expired, damaged, returned, recalled, or suspected falsified products to prevent their re-entry into the supply chain.

A cornerstone of this initiative is the reinforcement of pharmaceutical supply chain traceability in Kenya. Dr. Mohamed highlighted that reliable records and effective traceability are indispensable for establishing the origin and movement of products, facilitating prompt regulatory action when quality concerns emerge. He stressed that every regulated health product must be traceable throughout its distribution chain, as accurate records are vital for identifying affected products and coordinating timely interventions against substandard or falsified items.

In the Financial Year 2025/2026, the PPB conducted 3,453 compliance inspections, revealing an overall compliance rate of 82.4 percent, with 2,845 premises found to be compliant. Enforcement actions for non-compliance during this period included the closure of premises and arrests. Entities found with compliance gaps during the new inspections will be mandated to implement corrective and preventive measures within specified timeframes. The PPB has made it clear that appropriate regulatory action will be taken where non-compliance poses a risk to public health, underscoring that Good Distribution Practices are fundamental to public health protection. Dr. Mohamed urged all stakeholders, including hospitals, pharmacies, wholesalers, and transporters, to proactively review their operations and address any compliance deficiencies.

Lawyers and compliance officers advising pharmaceutical entities in Kenya should immediately review their clients' or organisations' Good Storage and Distribution Practices (GSDP) and supply chain documentation. This is crucial to prepare for the impending nationwide PPB compliance inspections, identify and address potential compliance gaps, and mitigate risks of enforcement actions including premises closure or arrests.

Source: Original reporting via the Pharmacy and Poisons Board